Provider handbook

Appendix 6: Sponsorship and activity guidelines for RACGP CPD approved activities

Use of generic product names

      1. Use of generic product names

Last revised: 01 Dec 2023

Use of generic product names 

Every drug has at least three names – chemical, generic (approved by the TGA) and brand. The chemical name describes the molecular structure of the drug. The sponsor usually selects the generic name (also known as the Australian-approved name), and the manufacturer or distributor of the drug usually selects the brand name. 

Generic names must be used wherever possible within CPD Program sponsorship. If, for any reason, it is necessary and justifiable that a branded product be named for a specific contextual purpose, the product must be named once only, and the trade name of all other products in the same drug class must also be named and given equal prominence. This applies to all presentations or materials. 

However, the use of products’ generic names is not always acceptable and caution is urged. Generic product names may, by reason of widespread use over a prolonged period of time, often be identified by users as the brand name of the drug (for example, aspirin). 

The RACGP recommends that the GP or medical specialist on the planning committee of the activity be the person to confirm the most appropriate use of names in any presentation or materials.